Eye - Table of Contents alert Volume 31 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 31, Issue 2 (February 2017) In this issue Cambridge Ophthalmological Symposiums Reviews Rcophth Eponymous Lectures Clinical Study Correspondence Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Follow us on Twitter Facebook Cambridge Ophthalmological Symposiums Top Regenerating reptile retinas: a comparative approach to restoring retinal ganglion cell function D L Williams Eye 2017 31: 167-172; advance online publication, November 11, 2016; 10.1038/eye.2016.224 Abstract | Full Text Hyper-IL-6: a potent and efficacious stimulator of RGC regeneration D Fischer Eye 2017 31: 173-178; advance online publication, November 25, 2016; 10.1038/eye.2016.234 Abstract | Full Text Whole-eye transplantation: a look into the past and vision for the future D Bourne, Y Li, C Komatsu, M R Miller, E H Davidson, L He, I A Rosner, H Tang, W Chen, M G Solari, J S Schuman and K M Washington Eye 2017 31: 179-184; advance online publication, December 16, 2016; 10.1038/eye.2016.272 Abstract | Full Text Why autophagy is good for retinal ganglion cells? P Boya Eye 2017 31: 185-190; advance online publication, December 16, 2016; 10.1038/eye.2016.278 Abstract | Full Text Electronic retinal implant surgery R E MacLaren Eye 2017 31: 191-195; advance online publication, January 6, 2017; 10.1038/eye.2016.280 Abstract | Full Text Targeting retinal ganglion cell recovery J G Crowston, E T Fahy, L Fry, I A Trounce, P van Wijngaarden, S Petrou and V Chrysostomou Eye 2017 31: 196-198; advance online publication, January 6, 2017; 10.1038/eye.2016.281 Abstract | Full Text The optical detection of retinal ganglion cell damage J E Morgan, J Tribble, J Fergusson, N White and I Erchova Eye 2017 31: 199-205; advance online publication, January 6, 2017; 10.1038/eye.2016.290 Abstract | Full Text An integrin approach to axon regeneration J W Fawcett Eye 2017 31: 206-208; advance online publication, December 23, 2016; 10.1038/eye.2016.293 Abstract | Full Text Assessing retinal ganglion cell damage C A Smith, J R Vianna and B C Chauhan Eye 2017 31: 209-217; advance online publication, January 13, 2017; 10.1038/eye.2016.295 Abstract | Full Text Protecting retinal ganglion cells T Z Khatib and K R Martin Eye 2017 31: 218-224; advance online publication, January 13, 2017; 10.1038/eye.2016.299 Abstract | Full Text Biomarkers for glaucoma: from the lab to the clinic N Von Thun Und Hohenstein-Blaul, S Kunst, N Pfeiffer and F H Grus Eye 2017 31: 225-231; advance online publication, January 13, 2017; 10.1038/eye.2016.300 Abstract | Full Text Reviews Top Fingolimod: therapeutic mechanisms and ocular adverse effects P Mandal, A Gupta, W Fusi-Rubiano, P A Keane and Y Yang Eye 2017 31: 232-240; advance online publication, November 25, 2016; 10.1038/eye.2016.258 Abstract | Full Text Uveal melanoma: relatively rare but deadly cancer S Kaliki and C L Shields Eye 2017 31: 241-257; advance online publication, December 2, 2016; 10.1038/eye.2016.275 Abstract | Full Text The evidence informing the surgeon’s selection of intraocular lens on the basis of light transmittance properties OPEN X Li, D Kelly, J M Nolan, J L Dennison and S Beatty Eye 2017 31: 258-272; advance online publication, December 9, 2016; 10.1038/eye.2016.266 Abstract | Full Text Effectiveness and safety of nutritional supplements in the treatment of hereditary retinal dystrophies: a systematic review N Brito-García, T del Pino-Sedeño, M M Trujillo-Martín, R M Coco, E Rodríguez de la Rúa, I del Cura-González and P Serrano-Aguilar Eye 2017 31: 273-285; advance online publication, December 9, 2016; 10.1038/eye.2016.286 Abstract | Full Text Rcophth Eponymous Lectures Top Evolution of the circuitry for conscious color vision in primates J Neitz and M Neitz Eye 2017 31: 286-300; advance online publication, December 9, 2016; 10.1038/eye.2016.257 Abstract | Full Text The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on J K Dart Eye 2017 31: 301-332; advance online publication, January 20, 2017; 10.1038/eye.2016.284 Abstract | Full Text Clinical Study Top Prevalence of referable, sight-threatening retinopathy in type 1 diabetes and its relationship to diabetes duration and systemic risk factors A N Warwick, A P Brooks, C Osmond and R Krishnan Eye 2017 31: 333-341; advance online publication, January 27, 2017; 10.1038/eye.2016.294 Abstract | Full Text Correspondence Top Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option D Călugăru and M Călugăru Eye 2017 31: 342; advance online publication, November 4, 2016; 10.1038/eye.2016.238 Full Text Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option M Ashraf, A Souka, R Adelman and S H Forster Eye 2017 31: 342-345; advance online publication, November 4, 2016; 10.1038/eye.2016.233 Full Text Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ E H C van Dijk and C J F Boon Eye 2017 31: 345-346; advance online publication, November 4, 2016; 10.1038/eye.2016.242 Full Text Response to ‘Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’’ P Scholz, L Altay and S Fauser Eye 2017 31: 346; advance online publication, November 4, 2016; 10.1038/eye.2016.245 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Eye. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.